A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Doxil Topotecan Doublet Cancer Study
- Status
- COMPLETED
- Phase
- PHASE1
Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC
- Status
- COMPLETED
- Phase
- PHASE2
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
- Status
- COMPLETED
- Phase
- N/A
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa
- Status
- COMPLETED
- Phase
- PHASE3
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
- Status
- COMPLETED
- Phase
- PHASE3
The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2